Related Experiment Video
Updated: Feb 8, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
TMEM205 promotes M2-like macrophage polarization and advances the progression of triple-negative breast cancer
Yining Zhang1, Jing Peng1, Teng Ma1
1Breast Disease Center, the Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Introduction:
Triple-negative breast cancer (TNBC) is a highly aggressive subtype and lacks effective targeted therapies. Transmembrane protein 205 (TMEM205) has been implicated in tumor progression and immune resistance, but its precise role and mechanism in TNBC remain unclear. This study aims to explore the function and mechanism of TMEM205 in TNBC progression, as well as its impact on the tumor immune microenvironment.
Methods:
The expression and prognostic significance of TMEM205 in breast cancer were analyzed using datasets, such as TCGA and UALCAN. TMEM205 was overexpressed and knocked down in TNBC cell lines (MDA-MB-231 and BT-549), and the effects on cell biological activity were verified by functional assays, including CCK-8, colony formation, wound healing, and Transwell assays. A coculture system of tumor cells and THP-1-derived macrophages was established. Key signaling molecules of TNBC cells were detected by Western blot, and cytokine levels by ELISA, so as to study tumor cell-macrophage interactions. The role of TMEM205 in tumor growth and angiogenesis was further validated through xenograft mouse models and endothelial tube formation assays.
Results:
TMEM205 was significantly upregulated in breast cancer tissues and associated with a poor prognosis. TMEM205 overexpression promoted the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of TNBC cells, while TMEM205 knockdown inhibited their biological functions. Furthermore, TMEM205 overexpression not only increased the secretion of IL-6 but also activated the JAK2/STAT3 signaling axis, showing a positive correlation with M2 macrophage infiltration. The TNBC cell-conditioned medium with TMEM205 overexpression significantly promoted endothelial cell angiogenesis.
Conclusion:
TMEM205, as a multifunctional oncoprotein in TNBC, jointly drives tumor progression by promoting cell proliferation, metastasis, angiogenesis, and fostering an immunosuppressive microenvironment via M2 macrophage polarization. TMEM205 may be a promising therapeutic target for TNBC.
Insights
Transmembrane protein 205 (TMEM205) drives triple-negative breast cancer (TNBC) progression by promoting cell growth, metastasis, and angiogenesis. It also creates an immunosuppressive tumor microenvironment, suggesting TMEM205 as a potential therapeutic target for TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapy options.
- The role of transmembrane protein 205 (TMEM205) in TNBC progression and immune evasion is not well understood.
Purpose of the Study:
- To investigate the function and mechanism of TMEM205 in TNBC.
- To assess TMEM205's impact on the tumor immune microenvironment.
Main Methods:
- Analyzed TMEM205 expression and prognostic value using TCGA and UALCAN datasets.
- Performed in vitro functional assays (CCK-8, colony formation, wound healing, Transwell) in TNBC cell lines with TMEM205 overexpression/knockdown.
- Utilized coculture systems, Western blot, ELISA, and xenograft mouse models to study tumor-macrophage interactions, signaling pathways, and tumor growth.
Main Results:
- TMEM205 is upregulated in breast cancer and linked to poor prognosis.
- TMEM205 overexpression enhances TNBC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
- TMEM205 upregulates IL-6, activates JAK2/STAT3 signaling, correlates with M2 macrophage infiltration, and promotes angiogenesis.
Conclusions:
- TMEM205 promotes TNBC progression through proliferation, metastasis, angiogenesis, and immune suppression via M2 macrophage polarization.
- TMEM205 represents a potential therapeutic target for triple-negative breast cancer.
More Related Videos
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
08:37Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Molecular Shape and Polarity
Group Polarization
The Eukaryotic Promoter Region
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Negative Regulator Molecules